Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Cardiovascular Disease in Patients With Chronic Kidney Disease
NCT01537315Phase 2Terminated
- Sponsor
- University of Arkansas
- Start
- Feb 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in cardiovascular disease (CVD), atherosclerosis, sponsored by University of Arkansas. Started Feb 2012; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
cardiovascular disease (CVD)atherosclerosis
Beyond the preview
Go deeper on NCT01537315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01537315.